Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS        
Revenue $ 37,003 $ 33,257 $ 96,667 $ 92,187
Cost of goods sold 29,668 28,639 81,117 82,794
Gross margin 7,335 4,618 15,550 9,393
Operating expenses:        
Research and development 2,267 2,188 6,558 6,805
Selling, general and administrative 6,991 6,816 21,200 20,692
Total operating expenses 9,258 9,004 27,758 27,497
Loss from operations (1,923) (4,386) (12,208) (18,104)
Other (expense) income (2)   (22) 26
Interest expense (176) (205) (538) (524)
Change in fair value of warrant liability   304 10 755
Loss before income taxes (2,101) (4,287) (12,758) (17,847)
Provision for income taxes 88 190 117 586
Net loss $ (2,189) $ (4,477) $ (12,875) $ (18,433)
Net loss per common share-basic and diluted (in dollars per share) $ (0.01) $ (0.01) $ (0.04) $ (0.06)
Weighted average shares used to calculate net loss per common share (in shares) 308,407 304,418 306,044 301,376